_256_384.png)
The company plans a phased expansion across India, focusing initially on metro cities and early-adoption hubs
Q2 2026 analysis shows expanding approvals, stronger uptake, and a shift toward evidence-driven biosimilar evaluation
Experts call for integrated, evidence-based approaches to tackle rising dengue, malaria, and chikungunya burden in Indian cities
Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region
_and_Dr__D_Nageshwar_Reddy_(AIG_Hospitals)_256_384.jpg)
The collaboration is designed to improve clinical outcomes, reduce procedural risks, and expand access to advanced image-guided treatments across a growing range of conditions
Sanplatec is leading the industry in the field of containers and devices for cell culture and live transport
Three-day programme focuses on advanced socket design, myoelectric technology and clinical skill development
CLIRNET plans to expand globally and improve how medical knowledge is shared and used in practice
Solvents made from renewable feedstocks help reduce reliance on fossil-fuel-based materials
This includes 14.3 million views on YouTube and 9.8 million views on Meta platforms to amplify preventive heart health message
Subscribe To Our Newsletter & Stay Updated
